Refreshing results…
Sotorasib is a pan-RASG12C inhibitor capable of driving clinical response in NRASG12C cancers
UploadData from Oncogenic Drivers and Therapeutic Vulnerabilities in KRAS Wild-Type Pancreatic Cancer
UploadMissing publications? Search for publications with a matching author name.